单孔胸腔镜肺大疱切除术治疗自发性气胸的效果分析

目的探讨单孔胸腔镜肺大疱切除术治疗自发性气胸的效果。方法抽取2016-12—2018-03间在信阳市中心医院治疗的50例肺大疱合并自发性气胸患者,均予以单孔胸腔镜肺大疱切除术治疗。观察手术时间、术中出血量、术后VAS疼痛评分、并发症发生率、住院时间及复发率。结果 50例患者均顺利完成手术,无中转开胸及增加辅助切口病例。手术时间为46～82 min,术中出血量为10～50 mL,术后24 h的VAS评分为2～4分,留置管引流时间24～78 h,住院时间3～6 d。未发生肺不张、肺部感染、肺漏气等术后并发症,患者均痊愈出院。术后随访12～18个月,未出现复发病例。结论单孔胸腔镜肺大疱切除术治疗肺大疱合并自发性气胸,具有创伤小、恢复快、复发率低等优点,但应严格掌握手术适应证。     

单孔胸腔镜治疗自发性气胸

目的：探讨单孔胸腔镜治疗自发性气胸的可行性。方法回顾分析2010年7月～2013年7月114例单孔胸腔镜手术治疗自发性气胸的临床资料,均采用自制可弯曲双关节腔镜专用器械行单孔胸腔镜手术。结果手术均顺利完成,无中转开胸,未增加穿刺孔,无术后大出血等并发症。手术时间（42．4±11．4） min,术后胸管留置时间（1．8±0．4） d,术后住院时间（5．4±3．4）d。术后随访1～36个月,平均20个月,其中76例＞12个月,无切口感染、出血、积液、气胸复发等并发症。结论单孔胸腔镜手术治疗自发性气胸是安全、微创、可行的。     

单孔胸腔镜手术联合中心静脉导管引流与单操作孔胸腔镜手术治疗自发性气胸的对比分析

目的 探讨自发性气胸采用单孔胸腔镜手术联合中心静脉导管引流与单操作孔胸腔镜手术治疗的效果。方法 回顾性分析66例于2016年1月至2016年8月期间我院施行单孔胸腔镜联合中心静脉导管引流或单操作孔胸腔镜手术治疗原发性自发性气胸的患者,分为单孔导引组（n=21）和单操作孔组（n=45）,观察两组治疗效果。结果 单孔导引组术后胸管留置时间、术后疼痛与单操作孔组比较有明显差异性（P<0.05）;两组术中出血量、手术时间和术后复发率比较无明显差异（P>0.05）。结论 两种手术方式均安全、有效。单孔胸腔镜手术联合中心静脉导管引流治疗自发性气胸法创伤小、疼痛轻。     

剑突下入路单孔胸腔镜手术治疗自发性气胸30例

目的探讨剑突下入路单孔胸腔镜手术治疗自发性气胸的安全性和可行性。方法回顾性分析2014年8月至2016年1月间剑突下入路单孔胸腔镜手术治疗自发性气胸30例患者的临床资料,其中男19例、女11例,年龄16~28(20.5±5.2)岁。结果手术均顺利完成,无中转开胸,无术后出血、漏气等并发症。手术时间(30.5±12.4)min,术中出血量(20.0±10.0)ml,术后胸腔引流管留置时间(1.5±0.8)d,术后住院时间(3.5±0.5)d。术后随访1个月,无复发、感染等其他并发症。结论剑突下入路单孔胸腔镜手术治疗自发性气胸安全、可行。     

电视胸腔镜手术治疗自发性气胸130例

目的探讨电视胸腔镜手术(video assisted thoracoscopic surgery,VATS)治疗自发性气胸的价值。方法 1999年3月～2009年12月,对130例自发性气胸行VATS下肺大疱切除及胸膜固定术。结果 130例手术均成功,无中转开胸。手术时间30～150min,平均45min;术中出血50ml。1例术后出现血胸,24h引流量700ml,二次VATS探查出血原因为胸壁粘连带钛夹脱落。10例漏气时间4d,均为合并慢性阻塞性肺疾病患者。术后住院3～10d,平均5d。130例随访1～84个月,平均48个月,无复发。结论 VAIS安全可靠、创伤小,是治疗自发性气胸的首选方法 。     

电视胸腔镜手术治疗自发性气胸55例

目的探讨电视胸腔镜手术（video-assisted thoracoscopic surgery，VATS）治疗自发性气胸的疗效。方法2000年3月-2003年11月，我们对55例自发性气胸行电视胸腔镜肺大疱切除术，其中右侧气胸32例，左侧20例，双侧3例。单纯性气胸50例，合并血胸5例。结果手术均获成功，6例因胸腔广泛粘连做辅助小切口。手术时间30—60min，平均40．7min。术后1—6d，平均2．3d拔管。住院时间3～9d，平均5．4d。50例随访6—30个月，平均17．6月，1例术后6个月复发，穿刺抽气后未再复发。结论VATS治疗自发性气胸，具有创伤小，效果可靠，复发率低等优点，是最佳治疗方法。     

单孔与三孔电视胸腔镜手术在自发性气胸中的应用效果比较

目的观察单孔与三孔电视胸腔镜手术治疗自发性气胸的临床效果。方法 110例自发性气胸患者,根据治疗方法不同分为对照组与观察组,每组55例,对照组患者接受三孔电视胸腔镜手术治疗,观察组患者接受单孔电视胸腔镜手术治疗。比较两组手术指标、术后疼痛、血清炎症指标、随访气胸复发情况。结果观察组术中出血量、术后引流量少于对照组,观察组术后胸管引流时间、住院时间短于对照组(P0.05)。观察组术后2小时、术后24小时、术后48小时VAS评分均低于对照组(P0.05)。观察组术后1天、术后3天、术后5天CRP、IL-6、TNF-α水平均低于对照组(P0.05)。两组随访6～12个月复发率差异无统计学意义(P0.05)。结论单孔VATS治疗自发性气胸,术中出血量、术后引流量少于三孔VATS治疗,单孔组术后胸管引流时间、住院时间更短,术后疼痛程度更轻,对机体损伤更小。     

双孔法胸腔镜肺大疱切除治疗自发性气胸效果观察

目的分析双孔法胸腔镜肺大疱切除术治疗自发性气胸的效果。方法选取收治的107例自发性气胸患者,均行双孔法胸腔镜肺大疱切除术。观察切口长度、手术时间、术中出血量、术后引流量、术后疼痛程度、住院时间及并发症发生率。结果本组均未中转开胸,顺利完成手术。手术时间25~61 min,切口长度1.52~3.28 cm,术中出血量30~55 m L,术后引流量100~390 m L,住院时间5~8 d,术后疼痛评分0.75~1.56分。术后出现肺部感染5例,未出现血胸、漏气等并发症,患者均痊愈出院。结论双孔法胸腔镜肺大疱切除术治疗自发性气胸,手术时间较短,术后恢复快,疗效显著。     

电视胸腔镜手术治疗自发性气胸的临床应用

目的:探讨胸腔镜手术治疗自发性气胸的可行性及疗效。方法:经胸腔镜手术治疗自发性气胸16例。结果:手术过程顺利,术后均未发生严重并发症。疗效满意。结论: (1)肺大泡破裂自发性气胸是胸腔镜手术最佳的适应证,与传统开胸手术相比,胸腔镜手术具有患者创伤小,手术时间短,术后疼痛轻,康复快,符合美容要求等特点; (2)反复发作的单侧自发性气胸,行胸腔闭式引流术后持续漏气7d,双侧自发性气胸,不论是否同时发作都可考虑胸腔镜手术治疗; (3)自发性气胸并胸膜粘连可用胸腔镜辅助小切口行粘连松解肺大泡切除术; (4)为减少一次性材料的消耗,降低手术成本,可辅助小切口使用常规胸科手术器械完成手术; (5)为减少术后复发率需行胸膜固定术。     

单孔法与双孔法胸腔镜肺大疱切除术治疗自发性气胸的对比研究

目的比较单孔法与双孔法胸腔镜肺大疱切除术治疗自发性气胸的疗效。方法回顾性分析我院2013年5月~2014年4月109例单侧自发性气胸的临床资料,其中单孔组59例,双孔组50例,比较2组手术时间、术中出血量、术后总胸腔引流量、术后胸腔引流管留置时间、术后住院时间、并发症发生率、围手术期死亡率和术后疼痛评分。结果 2组均顺利完成手术,无中转开胸及围手术期死亡。2组手术时间无明显差异[(57.7±21.5)min vs.(60.3±26.8)min,t=-0.562,P=0.575];单孔组术中出血量中位数明显少于双孔组(10 ml vs.20 ml,Z=-2.411,P=0.016);单孔组术后总胸腔引流量中位数明显少于双孔组(110 ml vs.312 ml,Z=-5.168,P=0.000);单孔组术后胸腔引流管留置时间明显短于双孔组[(2.8±0.9)d vs.(4.2±2.8)d(t=-3.628,P=0.000];单孔组术后住院时间明显短于双孔组[(3.7±1.1)d vs.(4.7±3.0)d,t=-2.380,P=0.019];单孔组术后NRS法疼痛评分明显小于双孔组[(3.3±1.5)分vs.(4.8±1.6)分,t=-5.046,P=0.000]。2组各发生肺部漏气1例。2组患者术后1、3、6、12个月定期随访,随访12个月,无气胸复发。结论单孔法与常规双孔法胸腔镜肺大疱切除术治疗自发性气胸,疗效相当,在技术上是安全、可行的,单孔法疼痛更轻,恢复更快,更具有微创优势。     

电视胸腔镜治疗气胸血气胸30例

目的 探讨电视腔镜在气胸、血气胸治疗中的应用价值。方法 回顾分析采用电视胸腔镜治疗气胸、血气胸30例临床资料。结果 30例电视胸腔镜手术均获成功。仅有l例术中并发复张性肺水肿,抢救转危为安,无手术死亡。平均手术时间89分钟,平均住院时间为5．8天,全部痊愈出院。结论采用电视腔镜手术治疗气胸、血气胸安全、有效、微创。术中采用钛夹间断夹闭法操作方便、经济;高度警惕术中出现复张性肺水肿并发症。     

Ipsilateral recurrence frequency after video-assisted thoracoscopic surgery for primary spontaneous pneumothorax.

OBJECTIVE: We retrospectively evaluated the results of video-assisted thoracoscopic surgery for primary spontaneous pneumothorax and recurrence. METHODS: A series of 424 patients with primary spontaneous pneumothorax were treated by video-assisted thoracoscopic surgery-289 with an ipsilateral recurrent episode, 88 with persistent air leakage for 7 days or longer, 34 with a contralateral episode, 9 with hemopneumothorax, and 4 with tension pneumothorax. The commonest management was stapling of an identified bleb, undertaken in 375 patients (88.4%). Pleural abrasion was conducted in 250 (59.0%), but the abraded area was one-third or less of the thoracic cavity in 187 (74.8%). RESULTS: No operative deaths occurred. Revisional thoracotomy was required in 1 patient with postoperative bleeding and another with incomplete postoperative lung reexpansion; 26 had prolonged air leakage, but none required revisional thoracotomy. During a mean follow-up of 31.4 months, ipsilateral pneumothorax recurred in 40 patients (9.4%), with 26 (65.0%) having recurrence within 1 year postoperatively. A video-assisted thoracoscopic surgery was conducted again in 8, and thoracotomy in 14. CONCLUSIONS: The ipsilateral recurrence of primary spontaneous pneumothorax after video-assisted thoracoscopic surgery was high at 9.4%. If video-assisted thoracoscopic surgery is to be considered as a treatment for spontaneous pneumothorax, we must therefore reduce postoperative ipsilateral recurrence by training practitioners not to overlook blebs during the procedure and/or consider widening the area of pleurodesis.     

Video-assisted thoracoscopic surgery for spontaneous pneumothorax--a 7-year learning experience

OBJECTIVES: To determine the effect of increasing experience of video-assisted thoracoscopic surgery (VATS) in the treatment of spontaneous pneumothorax (SP) on clinical efficacy and surgical practice. PATIENTS AND METHODS: A prospective study of 180 consecutive operations in 173 patients who underwent VATS for SP by a single surgeon during a 7 year period. RESULTS: 118 patients, mean age 32.1 years (range 13-63 years), were treated for primary spontaneous pneumothorax (PSP) while 55 patients, mean age 65.9 years (range 28-92 years), were treated for secondary spontaneous pneumothorax (SSP). All patients had VAT parietal pleurectomy combined in 162 (90%) patients with stapled bullectomy. At a current median experience of 2.0 years (range 0.4-6.8 years), 12 (6.6%) patients required reoperation for treatment failures within 12 months of surgery--9 patients within 30 days of VATS and 3 for late recurrent pneumothorax. Two patients (both with SSP) died within 30 days of surgery. When compared with PSP, VATS in SSP is characterized by an elderly, male predominance, a longer postoperative stay, a higher mortality rate and a lower rate of late recurrence. With increasing experience of the technique, there has been a significant decrease in treatment failures. In the treatment of PSP, both operating time and postoperative stay have decreased significantly with experience whilst the use of staple cartridges per patient has increased significantly with experience in both PSP and SSP. CONCLUSION: There is a demonstrable 'learning curve' effect on the clinical efficacy and surgical practice of video assisted thoracoscopic surgery for spontaneous pneumothorax.     

电视胸腔镜治疗弥漫型肺大疱合并自发性气胸的体会

目的:总结电视胸腔镜微创手术治疗弥漫性肺大疱合并自发性气胸的临床经验,以提高临床治疗水平。方法:回顾分析2007年3月至2011年2月21例弥漫性肺大疱合并自发性气胸患者的临床资料,均于全麻下行电视胸腔镜肺大疱切除术。以腋中线第7肋间为观察孔,腋前线第4、腋后线第7肋间为主、副操作孔,术中对不同的大疱组织采用不同的切除方法,并行胸膜摩擦固定。结果:21例手术均获成功,成功率100%。手术时间平均(105±11.2)min,术中出血量平均(90±10.1)ml。2例于术后3个月内复发,但肺压缩小于30%,余19例随访1年未见复发。结论:弥漫型肺大疱合并自发性气胸并非胸腔镜手术禁忌,只要采取有效的方法,同样可取得良好的治疗效果。     

急诊胸腔镜在自发性血气胸诊治中的应用

目的探讨急诊胸腔镜手术（video—assisted thoracoscopic surgery,VATS）在自发性血气胸诊治中的应用价值。方法2008年1月-2013年6月,急诊VATS治疗自发性血气胸37例,术中电凝或钛夹止血,同期切除肺大疱。结果全组手术顺利,无中转开胸,手术时间50～110min,平均70min。术后胸管留置时间1—5d,平均2．8d,住院时间3—9d,平均5．4d。全组治愈出院,无严重并发症及围术期死亡。32例随访12～24个月,平均17个月,无气胸或血气胸复发。结论急诊VATS治疗自发性血气胸安全有效,创伤小,恢复快,住院时间短,值得临床推广。     

单操作孔胸腔镜肺癌根治术的临床经验

【摘要】〓目的〓探讨单操作孔胸腔镜技术对治疗非小细胞肺癌患者的临床效果及应用价值。方法〓选取本院2013年1月至2015年12月接受治疗的早期肺癌患者共80例,根据严格病理筛选,其中行单操作孔胸腔镜手术患者40例,与同期传统开胸手术患者40例,比较两组患者术中出血量、拔出引流管时间、总引流量、淋巴结清扫数目、术后住院时间及术后并发症等。结果〓两组患者手术均顺利完成,无死亡现象出现。单操作孔组与传统开胸手术组比较,淋巴结清扫数目及手术时间无差异,但术中出血量、手术时间、引流时间、总引流量、术后住院时间等均有显著性差异。结论〓与传统开胸手术比较,单操作孔胸腔镜下手术在非小细胞肺癌患者治疗中创伤更小,恢复更快,具有较高的疗效及安全性。     

电视胸腔镜手术207例报告

目的总结电视胸腔镜手术(video-assisted thoracoscopic surgery,VATS)治疗胸部疾病的体会. 方法 1997年10月～2004年3月,开展VATS 207例,包括自发性气胸肺大疱结扎或切除155例,自发性或创伤性血气胸紧急探查止血30例,肺部良性疾病行肺楔形切除、活检14例,纵隔肿瘤摘除8例. 结果 190例经胸腔镜完成手术,12例附加胸部小切口,5例中转开胸手术.胸部手术时间20～180 min,平均56 min.术后住院5～52 d,平均9 d.术后并发症17例,占8.2%(17/207),其中肺泡漏9例,复张性肺水肿6例,胸腔感染2例.2例术后3～4个月自发性气胸复发. 结论 VATS治疗自发性气胸肺大疱、创伤性血气胸和某些胸部良性疾病较传统开胸手术具有更多优点,适时附加胸部小切口,积极防治并发症,可使VATS更安全.     

Three cases of emergency video-assisted thoracoscopic surgery for spontaneous hemopneumothorax]

We experienced 3 cases of video-assisted thoracoscopic surgery for spontaneous hemopneumothorax. All the patients had received emergent operations because of massive intrathoracic bleeding. At the operation, a 3 cm-minithoracotomy and 2 trocar ports were fashioned. In the head up position, massive blood clots in the apex in the thoracic cavity was removed by using grasping forceps and the source of bleeding point was detected easily. The bleeding was successfully stopped. It was difficult to remove massive blood clots from trocar port by suction, however it was easy to remove massive blood clots from a 3 cm-minithoracotomy window by using a large grasping forceps. Post operative course was satisfactory and the all patients discharged within 2 weeks after admission. We concluded that the spontaneous hemopneumothorax may be a good indication for video-assisted thoracoscopic surgery.     

VIDEO-ASSISTED THORACOSCOPIC SURGERY FOR PRIMARY SPONTANEOUS PNEUMOTHORAX

Video-assisted thoracoscopic surgery (VATS) has been suggested as the most appropriate choice for spontaneous pneumothorax. Thirty-two patients (30 males, two females, age range from 16 to 42) with primary spontaneous pneumothorax (PSP) are reported. All had mechanical pleurodesis with Marlex mesh. Blebs or bullae could be identified in 24 patients (75%). All bullae over 2 cm were either excised (11 patients) or ligated (five patients). The median operating time was 45 min. There was minimal postoperative discomfort and the median postoperative hospital stay was 4 days. There was one minor wound infection and one recurrence (mean follow up of 11 months). It is concluded that VATS is a quick, safe and effective approach for the treatment of PSP. Long-term results will better define its true merit in thoracic surgery.     

Video-assisted thoracoscopic surgery in spontaneous hemopneumothorax

We retrospectively studied the safety and utility of video-assisted thoracoscopic surgery (VATS) in the treatment of spontaneous hemopneumothorax. Of 128 cases of spontaneous pneumothorax operated on our hospital from April 1988 to October 1997, hemopneumothorax developed in 8 cases (2 cases treated by thoracotomy and 6 by VATS). In all 8 cases, bleeding points and pulmonary bullae were easily found and hemostasis and resection of pulmonary bullae conductedn quickly and safely. Two cases of VATS involved elective surgery. Of surgical emergent cases, the duration from visit our hospital to operation and surgical duration in VATS were almost as long as those in thoracotomy. The mean duration of postoperative chest drainage and postoperative hospital stay in VAST were less than in thoracotomy except for a VAST case with persistent air leakage. Blood loss from onset to operation and blood transfusion for VATS were almost equal to thoracotomy. Postoperative duration of analgesic use for VATS were shorter than that for thoracotomy. The VATS case with persistent air leakage should be necesary to reinforce the pulmonary stapled line or to convert to thoracotomy. In all cases, residual hematoma was found in the thoracic cavity. We conclude that early surgical repair should be performed once spontaneous hemopneumothorax is diagnosed and confirmed, and that VATS may be the first choice of surgery because it provides a better view and more facilitated manipulation during surgery than thoracotomy, and is a safe, nonaggressive therapeutic option.